Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenactol 50mg gastro-resistant tablets
1001010C0CJABAE
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | 36 |
|
Fenactol Retard 100mg tablets
1001010C0CJADAF
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | 4 |
|
Fenactol SR 75mg tablets
1001010C0CJACAL
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | 2 |
|
Fenactol 25mg gastro-resistant tablets
1001010C0CJAAAD
|
Fenactol | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.